Holen Sie sich die Stockscreener-App
7.2702
4.84%
-0.3698
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight Inc Stock (ISIN: US78419L1008) Faces Analyst Pressure After Q4 Revenue Drop - AD HOC NEWS
(RXST) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Stifel cuts RxSight stock price target to $9 on revenue guidance - Investing.com South Africa
Stifel Nicolaus Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price - MarketBeat
RxSight Inc. (RXST) PT Lowered to $9 at Stifel After Prudent Guidance - StreetInsider
RxSight Earnings Call: Strong Core, Cautious Outlook - TipRanks
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Change - Yahoo Finance
Midday Stock Roundup: Staar Falls 3.8% After Q4 Miss - Orange County Business Journal
Forecast Cut: Will RxSight Inc stock go up in YEARJuly 2025 Outlook & High Return Stock Watch Alerts - baoquankhu1.vn
RxSight (RXST) Q4 2025 Earnings Call Transcript - AOL.com
RxSight (RXST) COO granted 32,218 RSUs vesting through 2029 - Stock Titan
2026-03-03 | RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
RXST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Interest in RxSight, Inc. (NASDAQ:RXST) Expands By 29.3% - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2026-03-01 | Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation | NDAQ:RXST | Press Release - Stockhouse
Artisan Partners Limited Partnership Cuts Position in RxSight, Inc. $RXST - MarketBeat
RXST Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
RxSight, Inc. (RXST) Investor Outlook: Exploring a 28% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
RxSight, Inc. (NASDAQ:RXST) Q4 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), RxSight (RXST) and Cardiff Oncology (CRDF) - The Globe and Mail
RxSight Reports Fourth Quarter and Fiscal Year Financial Results - VisionMonday.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Responsive Playbooks and the RXST Inflection - Stock Traders Daily
Needham reiterates Buy on RxSight stock, keeps $13 target By Investing.com - Investing.com Australia
RxSight (RXST) Loss Deepens In Q4 Results Reinforcing Bearish Profitability Narratives - simplywall.st
What 5 Analyst Ratings Have To Say About RxSight - Benzinga
UBS Increases Price Target for RXST to $9.00 While Maintaining N - GuruFocus
RxSight (NASDAQ:RXST) Given New $9.00 Price Target at UBS Group - MarketBeat
RXST: Piper Sandler Lowers Price Target to $10.00, Maintains Neu - GuruFocus
RxSight (NASDAQ:RXST) Price Target Lowered to $10.00 at Piper Sandler - MarketBeat
UBS Adjusts Price Target on RxSight to $9 From $8, Maintains Neutral Rating - marketscreener.com
RxSight, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Needham Reiterates Buy Rating on RxSight Inc. (RXST) - StreetInsider
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance - The Manila Times
RxSight Q4 Earnings Call Highlights - MarketBeat
RxSight (NASDAQ:RXST) Issues Earnings Results - MarketBeat
RxSight, Inc. (RXST) Posts Fourth Quarter Loss, Surpasses Revenue Expectations - Bitget
Earnings call transcript: RxSight Q4 2025 beats EPS, revenue forecasts - Investing.com
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: RxSight Q4 2025 beats EPS, revenue forecasts By Investing.com - Investing.com Australia
RXSIGHT INC (NASDAQ:RXST) Reports Q4 Beat but Cautious 2026 Outlook Weighs on Shares - ChartMill
Rxsight earnings beat by $0.32, revenue topped estimates - Investing.com Canada
RxSight, Inc. (RXST) Tops Q4 EPS by 32c - StreetInsider
RxSight (RXST) Releases Q4 2025 Earnings: Revenue Down but Beats Estimates; Loss Narrows, EPS Beats - Quiver Quantitative
RxSight, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
RxSight (RXST) grows LAL volume but posts wider 2025 loss, soft 2026 outlook - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - Stockhouse
Earnings Update: Will RxSight Inc face regulatory challenges2025 Year in Review & Low Drawdown Trading Strategies - baoquankhu1.vn
Earnings To Watch: RxSight Inc (RXST) Reports Q4 2025 Result - GuruFocus
Analyst Calls: Can ProQR Therapeutics NV withstand a market correctionBuy Signal & Daily Momentum Trading Reports - baoquankhu1.vn
0.42%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):